title: [Differential diagnosis of thalassemia syndromes].
abstract: In Sardinia, as in other areas with a high incidence of thalassemia syndromes, a prevention program based on the detection of healthy carriers through mass screening and on prenatal diagnosis in the at-risk couples has been in course for several years. The commonly adopted beta-thalassemia flow-chart consists of a first operative step involving simple and widely standardized tests: the estimation of red cell indices, the measurement of Hb A2 and Hb electrophoresis. These investigations permit the identification of the majority of the at-risk couples for beta-thalassemia. However, the not infrequent evidence of Hb A2 borderline levels, with or without microcytosis, isolated microcytosis or Hb F increased values, causes some problems in differential diagnosis, because these findings can indicate the presence of silent beta-thalassemic traits or other beta-thalassemic like states. A diagnostic definition of these unusual hematological phenotypes is particularly important for the identification of eventual at-risk couples. In this paper we report our data concerning the voluntary screening for beta-thalassemia carried out in North Sardinia. The operative flow-chart is shown. In a population with a high incidence of phenotypically heterogeneous thalassemic syndromes, such as that of Sardinia, differential diagnosis of thalassemic traits can require molecular studies. This molecular characterization, which could be carried out in specialized reference centers, is today absolutely necessary both for exact identification of at-risk couples and eventual prenatal diagnosis.
authors.affiliation: Centro per la Microcitemia, Istituto di Ematologia ed Endocrinologia, Università degli Studi di Sassari.
authors.forename: F
authors.initials: F
authors.lastname: Dore
authors.forename: S
authors.initials: S
authors.lastname: Pardini
authors.forename: S
authors.initials: S
authors.lastname: Bonfigli
authors.forename: L
authors.initials: L
authors.lastname: Oggiano
authors.forename: M
authors.initials: M
authors.lastname: Murineddu
authors.forename: P
authors.initials: P
authors.lastname: Pistidda
authors.forename: L
authors.initials: L
authors.lastname: Guiso
authors.forename: L
authors.initials: L
authors.lastname: Frogheri
authors.forename: E
authors.initials: E
authors.lastname: Gaviano
authors.forename: M
authors.initials: M
authors.lastname: Longinotti
mesh_terms: D000328:Adult; D003937:Diagnosis, Differential; D005260:Female; D005319:Fetal Hemoglobin / Q000032:analysis; D006580:Genetic Carrier Screening; D006801:Humans; D007231:Infant, Newborn; D007558:Italy; D010641:Phenotype; D011247:Pregnancy; D011296:Prenatal Diagnosis; D012307:Risk Factors; D013577:Syndrome; D013789:Thalassemia / Q000175:diagnosis* / Q000235:genetics
chemical_list: D005319:Fetal Hemoglobin